Lymphocyte clones that are individually specific for structurally dissimilar epitopes can be functionally connected through shared idiotypy. Although idiotype sharing between antibodies binding to different epitopes was first reported in 1971 by Oudin and Cazenave (1), followed by repeated confirmations at the immunochemical level (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) , the biological consequences of such idiotype sharing have remained relatively uncharted. By incorporating unspecific parallel sets into the network hypothesis, Jerne (13) predicted the importance of shared idiotypy between lymphocyte clones specific for non-cross-reactive epitopes as a means of joining otherwise unconnected immune responses at the regulatory level.
Experimentally, the biological relevance of unspecific parallel sets is suggested by studies in the anti-hen-egg-white lysozyme (HEL) t system (2, 3) where antibodies directed against different epitopes on the lysozyme molecule share idiotype. Production of these antibodies is favored by an antiidiotypic helper T cell acting in concert with a classic lysozyme-specific helper T cell. Idiotypes such as those in the anti-HEL system that are coexpressed by different lymphocyte clones and that are targets for regulatory signals have also been called "regulatory idiotypes" by Bona et al. (14) . Furthermore, it has been postulated that regulatory idiotypes are germ line encoded and that idiotype dominance during induced antihapten responses is due to the connection of these responses with ongoing responses to environmental or endogenous stimuli by virtue of shared regulatory idiotypes (8, 15) . Idiotype sharing between induced antihapten responses and naturally occurring responses has been documented for the T15 (16), MOPC-460 (8) , and A strain cross-reactive idiotope (CRI)" (7) idiotype systems. Only in the T15 system do the induced and naturally occurring antibodies bind the same epitope.
In this report, we describe our first experiments aimed toward understanding the * Supported by grant AI 17090 from the National Institutes of Health. 1 Abbreviations used in this paper: ABA, p-azobenzenearsonate; BBS, borate-buffered saline; BSA, bovine serum albumin; CFA, complete Freund's adjuvant; CRI, cross-reactive idiotope; ELISA, enzyme-linked immunosorbent assay; H chain, heavy chain; HEL, hen egg-white lysozyme; HSA, human serum albumin; IFA, incomplete Freund's adjuvant; KLH, keyhole limpet hemocyanin; L chain, light chain; Nase, antistaphylococcal nuclease system; PAGE, polyacrylamide gel electrophoresis; PBS, phosphate-buffered saline; RID, radial immunodiffusion; SDS, sodium dodecyl sulfate; TBBD, BBS containing 1% BSA, 0.02% Tween-20, and 1 rag/m| dextran sulfate.
role and extent of idiotype coupling between immune responses to non-cross-reactiveimmunosorbent assay (ELISA), in which the amount of rabbit antibody in the column effluents reactive with CRI-coated polystyrene tubes (2054; Falcon Labware, Div. of Becton, Dickinson & Co., Oxnard, CA) was measured with protein A (P-9267) conjugated to alkaline phosphatase (type VII-S; Sigma Chemical Co.). Rabbit antiidiotype antibodies to be coupled to alkaline phosphatase were further purified from idiotype-specific antisera by affinity chromatography on, and chaotropic elution from, a serum idiotype-Sepharose column.
Two sets of antisera specific for mouse isotypes were used. One was generously supplied by Dr. Anne Good, University of California, Berkeley, and the other was purchased from Miles Laboratories, Inc., Research Products Div., Elkhart, IN. Other antisera include goat anti-mouse K light chain (21-1079; Nordic, London, United Kingdom), rabbit anti-mouse ~. light chain (64-367; Miles Laboratories), goat anti-rat IgG (12511; N.L. Cappel Laboratories Inc., Cochranville, PA), and goat anti-rat isotypes (Pel-Freeze Biologicals, Rogers, AR).
Mice were immunized variously as described in the text. CFA-induced and anti-ABA-KLH hyperimmune ascites were prepared as described by Tung et al. (18) .
Preparation of Ig Chains and Fragments. Fab fragments were prepared from IgG by digestion
with papain (Sigma Chemical Co.) for 5 h at 37°C (21) . Fab fragments were purified by gradient elution from DEAE cellulose by using a 2.5-100 mM phosphate gradient at pH 8.0. The fragments were sized by gel filtration on Sephadex G-100 and passed over a protein A Sepharose CL-4B column at pH 8.5 to remove residual Fc fragments and IgG. Analysis by gradient sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis (PAGE) and immunoelectrophoresis revealed only Fab fragments. Heavy (H) and light (L) chains from normal A/J IgG and serum idiotype were prepared by reduction with 0.02 M dithiothreitol and alkylation with 0.12 M iodoacetimide in N2 (22) . The H and L chains were separated in 1 M acetic acid by chromatography on Sephadex G-100 at 4°C. Serum idiotype and nIgG controls were similarly processed, but without reduction and alkylation. The separated chains and the Ig were dialysed vs. phosphate-buffered saline (PBS), centrifuged at 15,000 rpm for 30 min, and the protein concentrations of the supernatants were determined from their optical densities. The molecular weights of the various species were determined on gradient SDS-PAGE. The H chains were mixed in all combinations with the L chains so that the final H/L optical density ratio was 2. Idiotype and Antibody Assays. An ELISA (Engvall and Perlman [23] ) was adapted to 96-well polystyrene microtiter plates so that an optical reader (Flow Laboratories, Inc., Irvine, CA) could be used to measure the extent of reaction. Microtest plates (Cooke type R, M220-29; Cooke Engineering Co., Alexandria, VA or Dynatecb Immulon II, Dynatech Laboratories, Inc., Alexandria, VA) were coated with 90 #1 of the relevant ligand for 5 h at 37°C or overnight at ambient temperature. The ligands, which were dissolved in BBS with 0.04% NAN2, included 10 #g m1-1 ABA-HSA, or 1.5-2.5 #g m1-1 of (a) serum idiotype or Fab fragments of serum idiotype, (b) normal A/J IgG or its Fab fragments, or (c) hydridoma proteins R16.7 or 36-65.
Before use, the wells were filled for a minimum of 30 min at room temperature with TBBD (BBS containing 1% BSA, 0.02% Tween-20 [P-137; Sigma Chemical Co.], and 1 mg/ml dextran sulfate). 95 #l of antibody solution or antibody-enzyme conjugate, which was premixed for 30 min with dilutions of various inhibitors when appropriate, was added in duplicate to the coated plates and allowed to react overnight at ambient temperature. Occasionally, this incubation was shortened to 5 h at 37*C. The wells were then rinsed by washing three times with H20, incubating for a minimum of 10 min with BBS-0.02% Tween-20, and washing again three times with H20. When an additional developing reagent was required, 100 p~l of the appropriate alkaline phosphatase-conjugated anti-Ig was diluted in TBBD, added to the plates, and incubated for 5 h at 37°C. The wells were then rinsed as above, and 100 ~1 of the substrate pnitrophenyl-phosphate (104-0; Sigma Chemical Co.) at 1 nag ml -~ in 0.05 M Na2CO3, pH 9.6 was added. The plates were usually incubated at 37°C until the positive control wells had an OD40s >0.5. The data were analyzed on a Hewlett-Packard model 85 computer (HewlettPackard Co., Palo Alto, CA) using programs generated in our laboratory. Anti-Ig antibodies, including affinity-purified rabbit anti-CRI, goat anti-rat Ig depleted of anti-mouse Ig activity, 5 Ci, and rabbit anti-mouse x and X L chains, were conjugated to alkaline phosphatase using the method described by Engvall and Perlmann (23) .
The standard inhibition assay for CRI ADs used idiotype-coated plates, 200 ng ml -a AD8 incubated with serial dilutions of sera or hybridoma proteins to be assayed for idiotype, and goat anti-rat Ig alkaline phosphate conjugates. An alternate assay for CRI ADS substituted ADSbiotin for ADS and was developed with 1:300 dilutions of avidin-alkaline phosphatase (A-2100; Vector Laboratories, Inc. Burlingame, CA). These two assays, when compared with a battery of eight monoclonal proteins, produced identical patterns of reactivity. The antiidiotypic probes in the CRI a and CRI ADs assays were, respectively, rabbit antiserum idiotype-alkaline phosphatase and 5 Ci-alkaline phosphatase. The idiotype content was determined from the linear regression of the linear portion of the inhibition curves, and is reported as either the serum dilution or the protein concentration giving 50% of the maximum OD405 value.
Anti-arsonate antibody was measured by incubating duplicate dilutions of sera on ABA-HSA-coated plates followed by rabbit anti-mouse K and )k conjugates. The specificity of this reaction was investigated by including a 3-mM concentration of the hapten 4-azo-his in the reaction mix, a concentration that completely inhibited specific interactions. Anti-ABA content was determined by interpolating the reactivity of the experimental dilutions onto the curve of a reference anti-ABA serum with a known anti-arsonate titer. The concentration of antiarsonate antibodies in our standard antiserum was established using the quantitative precipitation assay and serial dilutions of ABA-BSA. Isotypes were determined by Ouchterlony analysis and relative concentrations of isotypes were assayed using radial immunodiffusion (RID).
Hybridomas. The characteristics of the hybridomas used in this study are outlined in Table   I . Clones AD8 and BA6 were derived from male Lewis rats immunized intraperitioneally with 500/~g serum idiotype in 0.2 ml CFA, and boosted 10 d later with 500/lg serum idiotype in IFA. 3 wk later, the rats were boosted on four consecutive days with 300 #g serum idiotype in PBS. These boosts were given intraperitoneally, except for the second boost, which was administered intravenously. The spleen was removed on the day following the last boost, and the spleen cells were hybridized with the Y3-Ag 1.2.3 rat myeloma cell line (24) using the 5 protocol of Oi and Herzenberg (19) , except that the cells were initially plated at 5 x 10 total cells per well in Microtest II plates (Dynatech Laboratories, Inc.). Supernatants were characterized using ELISA. Rat hybridomas were expanded in vitro before intraperitoneal transfer into nude mice that had been primed with 0.5 rnl of pristane on two occasions 7 d apart and at least 7 d before tumor transfer.
Mouse hybridomas were produced by fusing cells from immune A/J mice with the NS1 or SP2 cell lines using either the method of Oi and Herzenberg (19) or of de St. Groth and Scheidegger (25) . Hybridomas were grown either as ascites in pristane-primed CAF1 mice or in vitro using standard conditions. Arsonate-specific antibodies were isolated using affinity chromatography on ABA-tyraminyl-Sepharose. 5H5 was grown in serum-free medium (50% F-12, 50% RPMI, 10/~g m1-1 transferrin, 10/~g ml -I human insulin, 2 mM glutamine, and 5 × 10 -5 M 2-mercaptoethanol), and was isolated on protein A-Sepharose columns. 
Results

Summa~" of Preliminary Observations.
A number of rat X rat hybridomas were produced that reacted with serum idiotype. Of this number, the antibody from hybridoma AD8 was found to be exceptionally reactive with monovalent Fab fragments of serum idiotype. In the studies that follow, AD8 and 5Ci refer to the monoclonal antiidiotypic hybridoma antibodies, CRI ADs and CRI sci refer to the antibodies containing the cognate idiotopes, and CRI" collectively refers to idiotopes recognized by our affinity-purified rabbit antiidiotypic probe. In the initial screen, it was found that i0/~g/ml of serum idiotype or its Fab fragments completely inhibited the binding of AD8 to serum idiotype Fab-coated plates, whereas similar concentrations of Fab fragments from normal IgG failed to inhibit. Fortuitously, this concentration of normal Fab fragments was just below that which reveals endogenous CRI AD8. For this reason, we initially failed to detect CRI ADs in normal Ig. The presence of ~9 /lg/ml CRI ADs in normal sera and CFA-induced ascites will be documented below. Further preliminary studies showed that the interaction between AD8 and serum idiotype Fab-coated plates could not be inhibited by the CRI-ABA + hybridoma protein from clone 31C3. Additionally, it was shown that several different rabbit anti-CRI" antisera would compete with AD8 for binding to serum idiotype. To determine if CRI A~8 is enriched in antibodies specific for ABA, A/J antisera to ABA-KLH and ABA-CGG were extensively depleted of anti-arsonate activity by passage through ABA-BSA-Sepharose columns. The CRI At)8 titers of these ABA-depleted sera were reduced ~200-fold, indicating that most of the CRI ADs moieties in ABA-immune sera co-purify with the anti-arsonate activity. Immunochemical and electrophoretic analyses showed that ADS was a rat IgG2b protein. Because these preliminary studies demonstrated that AD8 was indeed antiidiotypic and seemed to have a high affinity for its cognate idiotope, we selected this protein for further study.
Strain Distribution of CRI ADs is Similar to that of CRI a. VH loci that are linked to the Igh-C e haplotype, or to the related Igh-C ° haplotype, encode for a cross-reactive idiotype (CRI a, above) that is expressed on a substantial fraction of anti-arsonate antibodies (28) . Additionally, most idiotopes of this major cross-reactive idiotype can be found on single hybridoma proteins (26, 27, 29) .
In light of the above findings, expression of CRI ADs was examined during anti-ABA-KLH responses in nine strains of mice. As shown in Table II , only mice possessing A-strain VH genes produced CRI ADs during this response. In contrast, no CRI ADs was found in mice lacking A-strain VH genes. Regardless of their ability to make CRI ADs, all strains of mice produced similar amounts of anti-arsonate antibodies. These results show that the strain distribution of CRI ADs closely parallels that ofCRI a (28) . * Mice were primed with 150 #g ABA-KLH GFA intraperitoneally, and boosted 3 wk later with 150 #g ABA-KLH/IFA i.p. Antisera were collected 11 d after boosting. ~: CRI ^Ds levels determined using a standard ELISA, in which the binding of ADS (200 ng ml -t) to microtiter plates coated with 1.5 #g m1-1 of serum CRI was inhibited by duplicate serial dilutions of each antiserum, and the amount of bound ADS was measured using goat anti-rat Ig enzyme conjugates. The level of idiotype is reported as the serum dilution that inhibits 50% of the maximum OD4o5 value. No CRI ADs was observed in non-A strain mice.
Binding of AD8 to CRI ADs is Hapten Inh2bitable and H Chain Determined. The relation-
Results are expressed as geometrical means, with geometrical deviations in parentheses. § Antibody equivalents of anti-arsonate Ig were determined with a standard ELISA in which microtiter plates were coated with 10 #g ABA-HSA ml -a, incubated with 1:500 antisera dilutions, and developed using anti-mouse K and ~. L-chain enzyme conjugates. Antibody equivalents were calculated by comparison with the binding curve of a reference anti-ABA-KLH serum pool of known anti-ABA titer. Values followed by parentheses are geometrical means; geometrical deviations are in parentheses. All other values are from pooled antisera. ND, not determined.
ship of CRI AD6 to the antigen-binding site was investigated by using ABA haptens to compete the interaction between ADS and idiotype-coated plates. As a specificity control, the Fc-specific hybridoma protein BA6 was similarly assayed. In a preliminary study, neither AD8 nor BA6 were inhibited by concentrations of phenyl-glu-tyr-ABA <5 × 10 -3 M. Although these results suggested that the CRI AD6 idiotope is not within the arsonate-binding site, subsequent studies using hybridoma protein R16.7 instead of serum idiotype have shown that the CRI AD6 determinant is indeed hapten inhibitable (Table III) . Microtiter plates were coated with serum idiotype or hybridoma proteins R16.7 or 36-65, and the binding of AD8 to these plates was inhibited by dilutions of various ABA haptens. The results using R16.7-coated plates show that binding was inhibited by all haptens tested. ABA-tyrosine inhibited most efficiently (3.9 × 10 -6 M at 50% inhibition) whereas ABA-phenyl-propionic acid was the least efficient inhibitor (7.4 × 10 -4 M at 50% inhibition). However, when the inhibition of binding of ADS to 36-65 or serum idiotype was assayed, inhibition was observed only at very high hapten concentrations (~ 10 -8 M). At least two factors might explain this inconsistency: (a) The affinity of AD8 for 36-65 may be higher than for R 16.7. Results presented in Figure 2 B suggest that, indeed, the affinity of ADS for 36-65 is ~ 100-fold higher than for R16.7 (50% inhibition of AD8 binding is 0.11 #g m1-1 for 36-65 and 11/zg m1-1 for R16.7). (b) The affinity of R16.7 for ABA may be higher than that ABA-tyrosine 3.9 × 10 6 8.4 × 10 -4 >2.5 × 10 -3 4-azo-A-his 1.0 × I0 -~ >1.3 X 10 -3 >1.3 × 10 3 benzyl-glu-tyr-ABA 2.2 X 10 -5 >4 X 10 -a >4 × 10 -3 ABA-phenyl-proprionic acid 7.4 × 10 -4 >2.5 X 10 -2 >2.5 X 10 -2 * Plates were coated with 2 #g m1-1 of idiotypic protein in BBS, and were assayed using ELISA as in Table II , with the following modification: AD8 reactivity was measured using AD8-biotin, followed by avidin-alkaline phosphatase. The values are molar concentrations ofhapten that inhibit 50% of the idiotype-binding activity. Genetic studies have shown that, although CRI a is coded for by an A strain VH locus, optimal CRI a expression requires the appropriate L chain (31) . Although data presented in Table I on the strain distribution of CRI ADs are consistent with the involvement of the H chain variable region in the expression of CRI ADs, they do not speak to the role of the L chain in CRI aDs expression. The relative roles of both H and L chains in the formation of the idiotope CRI ADs was investigated by separating H and L chains from both serum idiotype and normal A/J IgG. Each H chain preparation was reeombined with one or the other L chains. These recombinant mixtures and the separated chains were assayed in the standard competition ELISA using AD8 and serum idiotype Fab-coated plates. Because our chain-separation protocol does not yield pure H chains, the role of the L chain in CRI ads expression must be inferred by comparing the relative effectiveness of the idiotype L chain vs. the normal L chain in restoring the idiotype to a CRI ADs H chain preparation.
This chain-recombination experiment revealed that the relative amounts of protein necessary to restore equivalent idiotypic antigenicity are: idiotype H and idiotype L, 1.0; idiotype H and normal L, 2.4; and idiotype H alone, 3.4. The idiotype L chain alone or combined with the normal H chain failed to inhibit at concentrations up to 20 #g m1-1. Endogenous CRI ADs occurs at 1 part in 1,000 in normal Ig and was below the range needed to influence our chain-recombination experiments. This experiment suggests that, although the AD8 idiotope is a an H chain-associated structure, the correct L chain is required for optimal expression. These findings are similar to the genetic and sequence studies in the CRI a system (31, 32) .
CRI ADs is Found in Normal Serum. In a series of control experiments we found that high concentrations of normal A/J IgG inhibited in our CRI ADs assays, suggesting that CRI ADs might also be found in normal A/J serum. To test this hypothesis, sera from 11 nonimmunized A/J mice were analyzed individually for CRI ADs and for anti-ABA activity. These values are compared with those of an ascites pool from A/J mice hyperimmune to ABA-KLH in Table IV . The average CRI ADs content in normal serum was estimated to be 9.4 /~g ml -t (range, 2.7-16.3 /~g ml-1). By contrast, the hyperimmune ascites pool contained 2,400/Lg m1-1 of the CRI ADs+ molecules. The CRI ADs in normal serum is probably not associated with an ABA-binding Ig because Table II . Antibody equivalents were estimated by comparison of the inhibition curves of each normal serum with the inhibition curve of the hyperimmune pool. CRI ADs content of the hyperimmune pool was determined by measuring the amount of antibody that was affinity purified on an AD8-Sepharose column. Normal sera value is expressed as the geometrical mean, followed parenthetically by geometrical deviation. § Anti-ABA values of normal sera were determined using ELISA in which sera were diluted 1:20, either with or without 3 mM 4-azo-his, incubated 3 h at 21°C, added to the plates, and processed in the standard fashion (Table II) . Control anti-ABA serum dilutions were completely inhibited by this procedure, but no specific binding of antibodies from normal sera to ABA was observed (P < 0.1370). The anti-ABA content of the hyperimmune pool was determined in a quantitative precipitin assay.
we failed to detect anti-ABA Ig in the serum with an assay sensitive to 10-100 ng Ig m1-1 and also because the CRI ADs in CFA-induced ascites is not removed by passage through an ABA-affinity column. This result is similar to that of Wysocki and Sato (7) for the CRI a system and to that of Dzierzak and Janeway (8) for the MOPC-460 system.
IgG Isotypes Associated with CRI ads on Arsonate-binding Serum Antibodies Differ from Those on Arsonate-nonbinding Serum Antibodies.
Initial studies of isotype distribution of ABA + CRI a serum antibodies isolated from ABA-KLH ascites indicated that most of the idiotype was found on the IgG1 (33) subclass. Subsequent investigations using both hybridoma technology (26, 27) and conventional immunization schemes (34) have shown that CRI" can be expressed on most subclasses. Because the isotype of a given antibody population may reveal clues about both the biological function of that population and the nature of its cognate antigen (i.e., TD, TI1, TI2 [35] ), we determined the isotypes of ABA-CRI AD8+ antibodies found in normal sera and compared them with the isotypic profile of anti-arsonate antibodies isolated from hyperimmune anti-ABA-KLH ascites.
The experiment shown in Table V was designed to reveal IgG subclass restrictions of CRI ADs in anti-arsonate IgG and in normal IgG. ABA + IgG was affinity purified on ABA-tyramine-Sepharose-4b from ascites induced by ABA-KLH in CFA, whereas normal IgG was purified from aseites induced by CFA alone. This choice was dictated by the need for a CFA control to compare with ABA-KLH/CFA-induced ascites and by the need for relatively large volumes of normal A/J serum to do the experiment. Additional experiments have shown that CRI ~°8 levels in normal sera and CFAinduced ascites fluid are indistinguishable. Nevertheless, we emphasize that we cannot presently rule out the possibility that CFA priming during ascites production alters the subclass distribution of CRI Ax)s. Although no anti-ABA activity was found in either CFA ascites or normal sera, the CFA ascites was extensively absorbed on an .~ Relative enrichment of four IgG isotypes eluted from protein A columns. Isotype concentrations were measured using RID and two sets of subclass-specific antisera from different sources. Relative enrichment at each pH is expressed as the ratio of the amount of isotype in each fraction of IgG over the amount of isotype in unfractionated normal A/J IgG. § Anti-arsonate Ig was affinity purified from pooled ascites fluid from A/J mice hyperimmune to ABA-KLH on an ABA-tyraminyl-affigel column and chaotropically eluted. II Normal A/J IgG was isolated from pooled ascites fluid induced by multiple intraperitoneal injections of 0.3 ml CFA/PBS (9:1) emulsion. Ascites fluid was run through an ABA-BSA column before isolation of the IgG by Na~SO4 precipitation, DEAE fractionation, and gel chromatography. ¶ Percent of total IgG that was purified at each pH. Protein content was determined using OD2s0 and ~g/~l = 1.4. ** Percent of total CRI ADs that was purified at each pH. CRI ADs content was determined using ELISA as in Table II. ABA-BSA-Sepharose to remove any possible anti-arsonate antibody before IgG purification. No anti-ABA antibody could be eluted. The two IgG preparations were each fractionated into subclasses by differential pH elution from staplylococcus protein A-Sepharose. The efficiency of the protein A fractionation step was monitored by RID by using two sets of subclass-specific antisera from different sources. Significant amounts of antibody were eluted at three pH values: 8.6, 5.5, and 4.5. These three fractions accounted for 93% of the total anti-ABA antibody adsorbed to the column and for 96% of the normal Ig. Insignificant amounts of protein desorbed at pH 7.0 (data not shown). Neither IgM nor IgA detectable by RID was found in any of the three fractions. The values of the different subclasses relative to the values of normal IgG before fractionation are shown for each elution pH. The pH 8.6 fraction was enriched 1.4-fold for IgG1 and depleted 10-fold of IgG2b, whereas neither IgGz~ nor IgG3 was detected in this pH fraction. The pH 5.5 fraction was enriched twofold for IgG2a, contained significant levels of IgG2u (0.6 × normal levels), and was depleted fivefold of IgG1 and IgG3. The pH 4.5 fraction was enriched fourfold for IgGa, contained significant levels of IgGza and IgGzb (1.0 and 0.6, respectively) and was virtually depleted of IgG1. Although the subclass fractionation was not absolute, it was sufficient to differentiate IgG1 from IgGz and IgG3.
The percentage of total IgG purified at each pH for both Ig preparations was calculated and compared with the percentage of idiotype contained in the same pH fractions. A striking difference was observed in the isotype association of CRI ADs in ABA ÷ IgG compared with CRI n°a in ABA-IgG. For anti-ABA IgG, CRI ADs was uniformly distributed across all three pH fractions (CRIADS/IgG ratios from 1.0 to 1.2). However, a quite different pattern was observed in the ABA-IgG: the IgGl-rich (pH 8.6) fraction was depleted 80% of CRI ADs, whereas the IgG3-IgG2a-rich (pH 4.5) fraction was enriched 230% for CRI ~s. This suggests that the CRI ~x~s found in normal IgG is preferentially associated with the IgG3 and IgGz subclasses. This subclass distribution is similar to that seen in TI-1 antibody responses (35) . On the other hand, after immunization with ABA-KLH, a strong thymus-dependent antigen, CRI ~Ds, is expressed as frequently on IgG1 as on the other subclasses. The bottom row of Table V lists the percentage of total IgG that contains CRI ADs, and shows that CRI Arts is enriched >200-fold in the ABA-specific antibody preparation compared with the normal Ig preparation.
CRI ADs is Found on at Least 80% of the Molecules Expressing CRI a in ABA-KLH-induced Ascites. Because the expression of CRI ADs closely parallels that of CRI a (Table II) (28) , it was important to determine the degree of association between the two idiotypes in ABA-KLH hyperimmune ascites. For this experiment, hyperimmune anti-ABA-KLH ascites fluid was absorbed with either AD8-Sepharose 4B or normal rat IgSepharose 4B. After absorption, the amounts of CRI ADs and CRI" remaining in the filtrate were determined. The results of this experiment are shown in Fig. 1 . Absorption on AD8-Sepharose removed >99% (Fig. 1 A) of the CRI ADs and ~80% (Fig. 1 B) of the CRI a from the hyperimmune anti-ABA-KLH ascites. On the other hand, the control normal rat Ig immunoadsorbant did not significantly remove any CRI ADs from the preparation. Additional assays (not shown) indicated that >99% of CRI 5el was removed by absorption on ADS-Sepharose. This experiment shows that, in an idiotype-rich anti-ABA-KLH ascites fluid, CRI ADs and CRI a are expressed on the same molecules at least 80% of the time. Under these conditions, CRI 5ci is practically always coexpressed on molecules containing the CRI A°8 marker. 
CRI Aos Can Be Expressed on A /J Hybridoma Proteins Independently of Either CRI a or
Anti-ABA Reactivity. The apparent expression of CRI ADs on ABA-normal mouse Ig contrasts with the finding that most of the CRI ADs in ABA-immune sera is associated with arsonate-binding molecules (see Summary of Preliminary Observations, above). These results suggest that CRI ADs is a new major CRI related to the CRI a family and, paradoxically, that the expression of this idiotope is not diagnostic for anti-ABA activity.
To further characterize the relationships between CRI ADs, CRI a, CR[ 5ci, and anti-ABA activity, we compared four CRI "+ hybridoma proteins (Fig. 2) . We modified the ELISA for idiotype by coating microtiter plates with hybridoma protein R16.7 instead of serum idiotype, and by inhibiting two additional antiidiotype preparations, rabbit anti-CRI" and 5Ci. Two of the proteins studied, 36-65 (26) and R16.7 (27) , are prototypic ABA + CRI a+ Ig that contain most, if not all, of the idiotypic determinants expressed on A/J CRI "+ antibodies. When compared with one another using the rabbit anti-CRI a probe ( Fig. 2A) , both 36-65 and R16.7 were excellent inhibitors. On the other hand, the ABA-proteins 5H5 and 3D10 were 100-and 200-fold less effective than 36-65 in inhibiting rabbit anti-CRI a, respectively. This same order of reactivity was observed when serum idiotype rather than R16.7 was used on the solid phase. When the four proteins were compared for CRI ADs expression (Fig. 2 B) , quite a different pattern emerged. The ABA-protein 5H5, which was one of the least effective inhibitors of rabbit anti-CRI", was the most effective inhibitor of ADS. Surprisingly, R16.7 was 85-fold less effective an inhibitor than 36-65, suggesting that the AD8 idiotope is less fully expressed on R16.7 than on 36-65 or 5H5. These two sets of observations demonstrate that CRI ADs expression can occur independently of the expression of either CRI a or arsonate binding. Complete dissociation of CRI" from CRI ADs was seen with protein AB2-37.2, which strongly expresses CRI ~ but which lacks CRI ~°s (data not shown). The independence of arsonate binding and CRI ADs is further underscored by the ABA-protein 3D10, which expresses CRI ADs with an antigenicity intermediate in effectiveness between proteins 36-65 and R16.7. Thus, CRI A°8, like CRI a (7), can be expressed on ABA-antibodies. Furthermore, all ABA-, idiotype-positive proteins that we have examined seem to express CRI A°s more effectively than they do CRI".
Because the relative inhibition profiles of these four hybridoma proteins varied widely between the rabbit anti-CRI a and the AD8 probes ( Figs. 2A and B) , we repeated the experiment using protein 5Ci, another monoclonal antiidiotype derived by Wysocki and Sato (Fig. 2C) (7) . The ABA-protein 3D10 as well as two prototypic proteins, 36-65 and R16.7, expressed CRI 5el very efficiently, whereas protein 5H5 completely lacks tlais idiotope.
Selective Stimulation of the ABA-Subpopulation of CRI ADs Correlates with Limited Responsiveness of the ABA + Subpopulation of CRI sos to ABA-KLH.
In the previous sections, it was shown that although CRI ADs expression could be dissociated from the expression of CRI a, CRI 5ci, and ABA binding, immunization with ABA-KLH regularly elicits antibodies having all of these markers. In this section, we will show that it is possible to selectively stimulate the ABA-CRI ADs+ set and that such stimulation correlates with limited responsiveness of the ABA + CRI ADs÷ set to ABA-KLH.
Selective immunization of the ABA-subpopulation of CRI A°8 is shown in Table  VI . On the basis of preliminary dose-response experiments using both normal rat IgG and ADS in the range of 1 ng to 100 #g per mouse, a dose of 40 #g per mouse was selected for this experiment. This dose was chosen because it stimulated the production of ABA-CRI ADs+ antibodies while causing only a marginal increase in anti-rat IgG antibodies. Artifactual inhibition of the CRI ADs assay by mouse anti-rat IgG antibodies was prevented by modifying the ELISA as follows: antiserum dilutions from AD8-or normal rat IgG-immunized animals were mixed with 100/~g m1-1 normal rat IgG and incubated 20 min at 37°C; an equal volume of this mixture was added to a solution of 200 ng/ml AD8 and incubated for 30 min; this solution was added to idiotype-coated plates and assayed for the inhibition of AD8 binding as described in Materials and Methods. In control experiments, this modification removed nonspecific inhibition of the CRI ADs assay produced by a standard mouse anti-rat IgG antiserum but did not reduce the apparent CRI ADs content of antisera from mice immunized with ADS. Specificity of this system for CRI ~ags was further established in a large series of experiments (c.f., Tables VII and VIII) in which normal rat IgG was used as an immunization control for ADS. In none of these experiments did normal rat IgG Table II , except that plates were coated with R16.7 instead of serum idiotype. The antiidiotypic nature of the response was confirmed by including 100 #g ml -] of normal rat IgG in the incubation mix to inhibit nonidiotypic interactions. § Determined by ELISA, in which microtiter plates were coated with R16.7 and the antiidiotypic probe was rabbit antiidiotype alkaline phosphatase conjugates. CRI" levels in group B were not significantly elevated when compared with group A (P < 0.1501), whereas both group C and D were significantly elevated (P < 0.0018 and P < 0.0001, respectively). Geometrical mean is followed by geometrical deviation. ][ Determined by ELISA, in which plates were coated with R 16.7 and probed with 5Ci-alkaline phosphatase conjugates. Only group D showed a significant increase (P < 0.0238) in CRI 5ei titer. ¶ Determined using ELISA as in Table II . Geometrical mean is followed parenthetically by geometrical deviation. P < 0.033 P < 0.023 P < 0.006 P < 0.321 * Mice were pretreated with 20/.tg of AD8 or nRatlg in PBS by intraperitoneal injection. 7 d later they were primed with 150/~g ABA-KLH/CFA i.p. and 3 wk later were boosted with 150/tg ABA-KLH/IFA i.p. Antisera were collected 7 d after boosting. :~ Antiserum dilutions that inhibit 50% of the binding of three different antiidiotypes in ELISA. Microtiter plates were coated with 2/.tg R16.7 m1-1. Constant concentrations of antiidiotypic reagents (AD8, rabbit antiserum idiotype-alkaline phosphatase, or 5Ci-alkaline phosphatase) were inhibited by serial dilutions ofn different antisera, and the amount of antiidiotype bound to the plates was determined using ELISA. § Determined using ELISA as in Table II. elicit an apparent increase in CRI ADs. For this reason, normal rat IgG immunization controls were omitted from some experiments (c.f., Table VI ).
In the experiment shown in Table VI , a single 40-/zg dose of AD8 stimulated a fivefold increase in CRI ADs titer compared with nonimmunized mice (Table VI, group B vs. group A) without any apparent increase in CRI", CRI 5ci, or anti-ABA antibody activity. This result suggests that giving a single 40-/zg dose of AD8 selectively stimulates the ABA-CRI ADs+ set. Repeated inoculations of AD8 were required to increase the CRI a and anti-ABA titers (Table VI, Table II , except plates were coated with hybridoma protein R16.7 instead of serum idiotype. Values expressed as geometrical means followed in parentheses by geometrical deviations. § Sera from animals that were bled 7 d after pretreatment. Students' t test between the nRatIg control group and the AD8 experimental groups indicated that a significant increase in CRI ADs content (P < 0.0001) occurred only in the mice that received 20/zg AD8. ]] Sera from animals that were immunized with 150/Lg ABA-KLH/CFA 7 d after pretreatment, boosted with 150/Lg ABA-KLH/IFA 3 wk later, and bled 7 d after boost. Significant suppression in the AD8-treated groups relative to the nRatIg control group appeared only in the group pretreated with 20 #g AD8 (P < 0.0033).
the titers of CRI ADs were not increased relative to those found for mice that received a single 40-#g dose of AD8. Immunization with ABA-KLH in PBS caused significant increases in CRI ~ci as well as in CRI", CRI ADs, and anti-ABA activity. To further document the selectivity of low doses of ADS for stimulating the ABA-CRI ADs+ set, hybridomas were made from mice immunized with 40 /.tg of AD8. None of the hybridomas were ABA + or CRI ~ci+. However, all of the CRI ADs+ hybridomas were cross-reactive in the CRI" assay (Fig. 2) . Like the ABA-CRI ADs+ antibodies found in normal sera, the ABA-CRI ADs+ hybridomas were either of the IgG2 or IgG8 subclasses. The ABA-CRI ADs+ hybridomas 2E2 and 5H5 cross-reacted in the CRI a assay, giving relatively shallow inhibition' curves when compared with the prototypic CRI a÷ hybridomas 36-65 and R16.7 (Fig. 2, and unpublished observations) . Because both serum and hybridoma ABA-CRI ADs+ antibodies give shallow inhibition curves in the CRI ~ assay, it is difficult to detect less than threefold changes in their concentrations. It is possible that this is the reason we failed to detect a significant increase in CRI ~ when 40 #g of AD8 was used as a stimulus. In all of our experiments, giving 20 /~g or more of AD8 has resulted in a 5-10-fold increase in CRI ADs concentrations. Together, the data from immunizations with AD8 contrast with the responses to ABA-protein conjugates. By using a single low dose of AD8, it is possible to selectively stimulate the ABA-CRI ADs+ set. This subpopulation is also CRI 5ci-and is possibly cross-reactive in the CRI a assay. By contrast, immunization with ABA-KLH selectively stimulates the ABA + CRI ADs+ set (Table VI and below) which is CRI ~ci+ and fully cross-reactive in the CRI" assay. Because each of the CRI ADs subpopulations could be selectively immunized, it was possible to determine if stimulating the ABAsubpopulation of CRI ADs affected subsequent responses of the ABA + subpopulation to ABA-KLH. If responsiveness of the ABA + CRI ADs+ set remains unaffected by prior stimulation of the ABA-CRI ADs+ set, it is unlikely that idiotopes such as CRI ADs are used as regulatory idiotopes. On the other hand, if responsiveness of the ABA + CRI ADs+ set is affected, it is possible that CRI ADs correlates with a regulatory idiotope.
Data presented in Tables VII and VIII suggest that boosting a prior response in the ABA-CRI ADs+ set is connected with reduced responsiveness in the ABA + CRI ADs+ set to ABA-KLH. The experiment shown in Table VII shows that AD8 can induce idiotype suppression in the anti-ABA-KLH response. A/J mice received 20 ttg of either AD8 or normal rat IgG followed by priming and boosting with ABA-KLH. 7 d after boosting the mice were bled and their sera assayed for anti-ABA antibodies, CRI a, CRI 5ci, and CRI ADs. All three idiotopes were suppressed (83% for CRI ADs, 85% for CRI", and 99% for CRISCi). Anti-ABA activity remained unchanged. These results are similar to those previously reported for idiotype suppression in the CRI a system (36, 37) . Like the CRI" system (37), idiotype suppression in the CRI ADs system can be transferred with cells (unpublished observations), which suggests an active mechanism and rules out possible effects of residual AD8 on the CRI ADs assay. Along with idiotype depletion experiments (see below), this experiment suggests that AD8 priming causes a significant reduction in the responsiveness of the ABA + CRI ADs+ set to ABA-KLH.
To correlate stimulation of the ABA-CRI ADs+ set with reduced responsiveness of the ABA + CRI ADs+ set to ABA-KLH, an experiment was performed in which the dose of AD8 was varied from 1/.tg per mouse to 20/~g per mouse in narrow increments. 7 d later and immediately before immunization with ABA-KLH, the mice were bled. The mice were bled again 7 d after priming and boosting with ABA-KLH, and both sets of sera were analyzed for CRI ADs. The results are shown in Table VIII . Doses of 10/zg or less of AD8 (groups A, B, and C) failed to reveal either significant stimulation of CRI ADs or significant suppression of CRI ADs after immunization with ABA-KLH. By contrast, doubling the dose of AD8 to 20/zg per mouse (group D vs. E) stimulated an ~ 10-fold increase in CRI ADs relative to the normal rat IgG control group (before immunization with ABA-KLH) and primed for 77% suppression of CRI ADs after immunization with ABA-KLH. Limited responsiveness of the ABA + CRI ADs+ set was verified by exhaustively depleting each of the individual anti-ABA-KLH antisera from groups D and E on ABA immunosorbents. Residual CRI ADs titers for the two groups were statistically indistinguishable (338 (x/+ 1.82) for group D and 324 (x/ + 2.10) for group E). These data show that in mice receiving 20 ttg ADS, the ABA + CRI ADs+ response to ABA-KLH is reduced by ~80%. Selectivity of ABA-KLH toward the ABA + CRI ADs+ set was shown by depleting sera from group E, both before and after ABA-KLH, on ABA immunosorbents and analyzing for residual CRI ADs. After depletion, the pre-ABA-KLH titer of CRI ADs was 100 (x/+ 1.65) whereas that for the post-ABA-KLH was 324 (x/+ 2.10), which indicates that ABA-KLH does not significantly stimulate the ABA-CRI ADs+ set.
Discussion
The experimental results described above suggest that shared idiotypy can functionally connect immune responses directed toward structurally dissimilar epitopes.
Furthermore, these data are consistent with the argument favoring a connection between idiotype dominance in induced antihapten responses and the prior occurrence of idiotypically related responses directed toward internal or environmental stimuli.
Our experiments were possible because of the serendipitous discovery of a rat monoclonal antiidiotype antibody detecting a new cross-reactive idiotope CRI ADs. In A strain or related mice, CRI ADs is found on both induced anti-ABA antibodies and naturally occurring antibodies not binding ABA. Furthermore, division of the CRI ADs idiotope family into two dominant subpopulations is supported by the lack of CRI 5ci expression in the naturally occurring ABA-CRI ADs+ set in contrast to the induced ABA + CRI ADs+ set that expresses CRI 5el. Each of these CRI ADs subpopulations could be selectively immunized. A single low dose of antiidiotype AD8 selectively stimulated the ABA-CRI ADs+ set. In contrast, immunization with ABA-KLH selectively stimulated the ABA + CRI ADs+ set. Because the CRI ADs subpopulations could each be selectively immunized, it was possible to study the effect of stimulating one subpopulation on subsequent responsiveness of the reciprocal subpopulation. If each subpopulation responds independently of the other after sequential stimuli, it is unlikely that sharing of CRI ADs by the two subpopulations is biologically important. If, however, shared idiotypy functionally connects these two responses, stimulating one subpopulation might modify subsequent responses of the reciprocal subpopulation. In principle, the experiment could be done by giving either ABA-KLH or AD8 first and then immunizing with the reciprocal stimulus. We chose to first give AD8 followed by ABA-KLH because this immunization schedule has been shown to elicit idiotypespecific suppression in the CRI a system (36) . Using this immunization schedule, the mice were bled before being given ABA-KLH to correlate responses in the ABA-(]RI nds+ set with the subsequent responsiveness of the ABA + CRI ADs+ set to ABA-KLH. These experiments suggest that stimulating the ABA-CRI ADs+ set dramatically limits the subsequent responsiveness of the ABA + CRI ADs+ set to ABA-KLH and that CRI ADs expression links the ABA-CRI ADs+ set with the ABA + CRI ADs+ at the regulatory level. Based on these observations, Jerne's original concept (13) of dissimilar immune responses being linked via unspecific parallel sets appears to he correct.
The strict interpretation of our findings should be qualified in two ways. First, the data connecting a response in the ABA-CRI ADs+ set with reduced responsiveness in the ABA + CRI ADs+ set were correlative, and as such, do not establish causality. Second, the selectivity of a single low dose of AD8 toward the ABA-CRI ADs+ set may be more apparent than real. Although repeated innoculations of ADS were required to induce even small ABA + responses, it is possible that AD8 stimulates a cryptic response in the ABA + CRI ADs+ set which leads to idiotype suppression after immunization with ABA-KLH. Without formally overcoming these objections, the experiment in which the dose of AD8 was varied in narrow dose increments argues against these interpretations. In this experiment, giving doses of 10/tg or less of AD8 failed to either reproducibly stimulate the ABA-CRI ADs+ set or to alter the responsiveness of the ABA + CRI ADs+ set to ABA-KLH. Doubling the dose of AD8 to 20 ~g both boosted the ABA-CRI ADs+ set and reduced the responsiveness of the ABA + CRI ADs+ set to ABA-KLH. Although these data are correlative, the repeated appearance of both boosting in the ABA-CRI ADs+ set and reduced responsiveness of the ABA + CRI ADs+ set, at exactly the same dose of ADS, suggests that the two phenomena are causally related. If a single low dose of AD8 induces a cryptic response in the ABA + CRI ADs+ IDIOTYPE CONNECTANCE IN TIlE IMMUNE SYSTEM subpopulation, leading to suppression after immunization with ABA-KLH, it seems unlikely that the dose response for this putative cryptic response would be the same as that found for boosting the ABA-CRI ADs+ set. The importance of immunizing with AD8 is further underscored by other experiments (data not shown) in which the ABA-CRI sci-CRI ADs+ hybridoma 5H5 was infused into normal A/J mice to levels approximating those elicited by AD8 before immunization with ABA-KLH. This manipulation had no effect on the subsequent responsiveness of the ABA ÷ CRI ADs+ set to ABA-KLH despite the similarity of protein 5H5 to the antibodies found in mice immunized with AD8 (5H5 was raised by immunization with AD8 before fusion).
Assuming that the reduced responsiveness of the ABA + CRI ADs+ set is due to boosting by AD8 of the ABA-CRI ADs+ set, the mechanism by which this boosting reduces the responsiveness of the ABA + CRI ADs+ set is a fertile area for new experiments. In form, our protocol is similar to that originally devised by Hart et al. (36) for suppressing CRI a, and because both CRI ADs and CRI a are found on ABAantibodies in the sera of unprimed mice, it is tempting to speculate that in both instances, idiotype suppression in the anti-ABA-KLH response is initiated by boosting the endogenous response with antiidiotype. If this is true, then antiidiotype antibodies that do not react with naturally occurring antibodies might not induce idiotype suppression using the present protocol since they would not boost an endogenous response. This interpretation could also apply to the recent studies of Nelles et. al. (38) , who made three monoclonal anti-CRI a antibodies and found that two would induce suppression whereas the third would not. We would predict that the former two antibodies can boost the endogenous CRI a response but that the third cannot. This interpretation could also be extended to the anti-staphylococcal nuclease system (Nase). Here, priming with an antiidiotype antibody induces serum idiotype with no specificity for Nase. Immunization with Nase after giving antiidiotype antibody fails to reveal suppression (11) . The CRI ADs and Nase systems are similar in that giving antiidiotype calls up idiotype with unknown antigen-binding specificities (12) . However, we would postulate that in the Nase system, the antiidiotype antibody is not boosting an endogenous response. Here the antiidiotype would be stimulating a de novo response. The possible connection between endogenous immune responses and idiotype dominance in induced antihapten responses has been made before in other systems (8, 15) . The experiments shown above lend further credence to this notion. To date, we have been unable to identify the stimulus responsible for the endogenous CRI ads. However, the IgG subclass restriction to IgG3 and IgG2 suggests that the naturally occurring CRI aDs is the result of a TI-1 antibody response (35) . Such responses are very often elicited by bacterial antigens that may be implicated in the endogenous response reported here. Our findings are similar to those in the MOPC-460 system where the endogenous idiotype was dramatically reduced in germ-free mice, implicating the endogenous flora as the relevant antigen (8) . Unfortunately, no germ-free strain A mice are available to do a similar experiment. We are now searching for the stimulus for the endogenous response.
At first glance, it would seem that only those idiotopes originally called unspecific parallel sets by Jerne (13) should function as regulatory idiotopes. By definition, the unspecific parallel sets are idiotopes that are distinct from the antigen-binding sites, and therefore, can be found on antibodies having dissimilar antigen-binding specificities. The usual criterion for antigen-binding site-associated idiotopes is the hapten inhibitability of the idiotope antiidiotope interaction. Our data on the hapten inhibitability of the AD8-CRI ADs interaction demonstrate that the criterion of hapten inhibitability should be used with caution for defining binding site-associated idiotopes. In our experiments, the 50% hapten-inhibition point for ADS binding to CRI ADs varied dramatically with the source of CRI ADs. When hybridoma protein R16.7 was used as the source of CRI ADs, its interaction with AD8 was inhibited by relatively low concentrations of free hapten. On the other hand, when serum CRI or hybridoma protein 36-65 were used as a source of CRI ADs, their interactions with ADS were inhibited by only very high concentrations of free hapten. In other experiments, the same concentrations of free hapten inhibited the interaction between normal Ig and a monoclonal antibody against IgG-Fc, suggesting that these hapten concentrations nonspecifically inhibit the AD8-CRI ADs interaction. Thus, depending on the source of CRI ADs, the AD8-CRI ADs interaction can appear to be more or less binding-site specific. Within the limits imposed by our relatively small sample size, it appears that the strength of the AD8-CRI ADs interaction varies inversely with the ease of hapten inhibition of this interaction. This statement is based on the observations that hybridoma protein R16.7 interacted with ADS very poorly when compared with either serum idiotype or 36-65, whereas the interaction of AD8 and R16.7 was inhibited by relatively low concentrations of hapten when compared with the high hapten necessary to compete the interaction of ADS with either serum CRI or 36-65. These findings agree with other reports (7, 8) showing that a binding site-related idiotope can be found on antibodies that have no demonstrable affinity for the original hapten. Furthermore, such an idiotope can be correlated with the cross regulation of two immune responses, each being specific for a different epitope. At the present, it is only safe to say that CRI ADs is correlated with the presence of a regulatory idiotope. It is not possible to say that CRI ADs is a regulatory idiotope since we have no direct data that the actual idiotope recognized by AD8 is, in fact, the same structure recognized by the regulatory elements of the immune system. Further studies using antiidiotypic T cells, autologous antiidiotype antibodies, and our panel of CRI ADs÷ and CRI ^Ds-hybridoma proteins will be required to answer this question.
Summary
A new cross-reactive idiotope family (CRI ADs) is described that contains subpopulations of antibodies binding to different epitopes. One subpopulation occurs naturally in normal sera from strain A mice, is found mainly on IgG2 and IgGa subclasses, does not bind p-azobenzenearsonate (ABA) +, does not express CRI 5ci, and can be selectively stimulated by low doses of antiidiotype antibody (AD8). The second subpopulation is not found in normal serum, binds ABA, is found on all IgG subclasses, expresses CRI 5ci, and is selectively stimulated by ABA-conjugated proteins. Since CRI ADs was found on both subpopulations of antibody, and since each subpopulation could be selectively expanded, it was possible to study the effect that expansion of the ABA-CRI ADs+ set had on subsequent responses elicited by ABA-keyhole limpet hemocyanin (KLH) in the ABA + CRI ADs+ set. In these experiments, prior immunization with AD8 restricted the subsequent response of the ABA + CRI ADs+ set to ABA-KLH. Furthermore, only those doses of AD8 that stimulated the ABA-CRI ADs+ set reduced the responsiveness of the ABA + CRI ADs+ set to ABA-KLH, suggesting that the two phenomena are causally related. These findings argue that CRI ADs correlates well with a regulatory idiotope and that immune responses by lymphocyte clones that have different antigen-binding specificities can affect one another as a result of their sharing such an idiotope. These results strongly favor a network organization of the immune system.
